Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling INR data to predict maintenance fluindione dosage

E Comets1, F Mentré, F Pousset

  • 1INSERM U436, Modélisation Mathématique et Statistique en Biologie et Médecine, Institut de Physiopathologie et de Génétique Cardiovasculaire, Centre Hôpital Universitaire Pitié-Salpêtrière, Paris, France.

Therapeutic Drug Monitoring
|December 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of Large Guide Field Electron-Only Reconnection in a Filamentary Current Sheet Immersed in a Large-Scale Magnetopause Reconnection Exhaust.

Physical review letters·2025
Same author

Population pharmacokinetics and pharmacodynamics of imipenem in neutropenic adult patients.

Infectious diseases now·2022
Same author

Impact of the first wave of the COVID-19 pandemic on French Health students.

L'Encephale·2022
Same author

Prognostic value of longitudinal strain and ejection fraction in Friedreich's ataxia.

International journal of cardiology·2021
Same author

[How I do…an intrauterine transfusion?]

Gynecologie, obstetrique, fertilite & senologie·2020
Same author

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav.

The Journal of antimicrobial chemotherapy·2020
Same journal

Mass Spectrometric Characterization of Flucloxacillin Binding to Serum Albumin in Hospitalized Patients With Hypoalbuminemia: An Observational Pilot Study.

Therapeutic drug monitoring·2026
Same journal

Therapeutic Drug Monitoring-Driven Prediction of Cyclosporine-Associated Liver Injury in Pediatric Thalassemia After Hematopoietic Stem Cell Transplantation.

Therapeutic drug monitoring·2026
Same journal

Donor-derived Cell-free DNA Does Not Improve the Detection of Acute Kidney Allograft Rejection Beyond Urinary CXCL9 and CXCL10.

Therapeutic drug monitoring·2026
Same journal

A Novel Dosing Strategy for Tacrolimus in Lung Transplant Recipients: Integrating Machine Learning with Population Pharmacokinetic Analysis.

Therapeutic drug monitoring·2026
Same journal

Recommendations for Assessing Methodological Quality in Systematic Reviews of Population Pharmacokinetic Models: A Systematic Review.

Therapeutic drug monitoring·2026
Same journal

Wide-Range Quantification of Belumosudil in Patients with Chronic Graft-Versus-Host Disease by High-Performance Liquid Chromatography.

Therapeutic drug monitoring·2026
See all related articles

This study developed a model to predict International Normalized Ratio (INR) changes during fluindione treatment. This model enables personalized fluindione dosing for improved oral anticoagulation therapy.

Area of Science:

  • Pharmacology
  • Pharmacokinetics/Pharmacodynamics
  • Clinical Pharmacy

Background:

  • Oral anticoagulation therapy is crucial for preventing thromboembolic events.
  • Fluindione is an oral anticoagulant requiring careful dosage monitoring.
  • Individual patient responses to fluindione can vary significantly, necessitating personalized dosing strategies.

Purpose of the Study:

  • To develop a pharmacokinetic/pharmacodynamic (PK/PD) model for fluindione's effect on International Normalized Ratio (INR).
  • To create a method for individualizing fluindione dosage regimens.
  • To establish predictive models for INR evolution during fluindione treatment.

Main Methods:

  • Constructed a PK/PD model using indirect response models to describe the concentration-INR relationship.

Related Experiment Videos

  • Employed a nonparametric estimation method to model INR as a product and elimination process.
  • Utilized a log-likelihood ratio test to select the best-fitting model, identifying fluindione's inhibition of INR elimination.
  • Validated the model in 24 additional patients and employed Bayesian methods for prediction and dosage individualization.

    • Main Results:

    • The study identified an indirect response model where fluindione inhibits INR elimination as the best fit.
    • The developed model accurately predicted INR levels at later time points (days 6 and 10) using data from earlier doses (day 4).
    • Population pharmacokinetic characteristics of fluindione were estimated.
    • A Bayesian method for individualizing fluindione dosage regimens was successfully developed.

    Conclusions:

    • A robust PK/PD model was established to describe INR evolution under fluindione therapy.
    • The developed Bayesian method allows for accurate prediction and individualization of fluindione dosage.
    • This approach facilitates the derivation of prescription rules for optimizing fluindione treatment and patient outcomes.